Ratings Fine Organic Industries Limited

Equities

FINEORG

INE686Y01026

Delayed NSE India S.E. Other stock markets 06:28:33 2024-04-24 am EDT			5-day change	1st Jan Change
4,451 ^INR	+2.90%		+3.65%	-10.58%

Mar. 28	Fine Organic Industries Limited Approves the Re-Designation of Jayen Shah from Chief Executive Officer to Managing Director of the Company	CI
Mar. 28	Fine Organic Industries Limited Announces Executive Changes	CI

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
According to Refinitiv, the company's ESG score for its industry is poor.

Strengths

The company returns high margins, thereby supporting business profitability.
Thanks to a sound financial situation, the firm has significant leeway for investment.
The opinion of analysts covering the stock has improved over the past four months.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 34.85 times its estimated earnings per share for the ongoing year.
The company's "enterprise value to sales" ratio is among the highest in the world.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The company is highly valued given the cash flows generated by its activity.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the past year, analysts have significantly revised downwards their profit estimates.
Over the past twelve months, analysts' opinions have been revised negatively.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
FINE ORGANIC INDUSTRIES LIMITED	-10.58%	1.59B	D+
ECOLAB INC.	+10.74%	62.8B	A-
SIKA AG	-5.96%	45.4B	A-
GIVAUDAN SA	+14.52%	40.32B	B+
FUJIFILM HOLDINGS CORPORATION	+20.63%	25.83B	A-
EMS-CHEMIE HOLDING AG	+4.63%	18.21B	C+
CELANESE CORPORATION	+0.46%	17.41B	B+
SYMRISE AG	+3.72%	15.64B	B+
POSCO FUTURE M CO., LTD.	-23.40%	15.51B	A-
ALBEMARLE CORPORATION	-20.96%	13.42B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes